Business & Finance |
PKS Holdings Limited (ASX: PKS)

PKS signs new agreement with SA Pathology

PKS Holdings Limited (ASX: PKS) is pleased to announce the signing of a new Software License and Support Agreement for RippleDown® Auditor and Expert with SA Pathology as its Clinical Decision Support Solution.


  • SA Pathology is recognised for the highest standards of medical testing and research, delivering quality pathology to medical practitioners and public and private hospitals through a linked system of laboratories across the state.

  • SA Pathology is investing in interconnected ICT/computer systems across their laboratories and worksites for better and faster communication.

  • The new agreement commences immediately for a 12-month period with the option to extend


SA Pathology is the state-wide pathology provider for the public health sector, an institution recognised for the highest standards of medical testing and research. SA Pathology provides a complete diagnostic and clinical service for patients and the South Australian population, delivering quality pathology to medical practitioners and public and private hospitals through a linked system of laboratories across the state.


SA Pathology is investing in interconnected ICT/computer systems across their laboratories and worksites for better, faster communication through the use of improved technology, while ensuring developments are clinically and scientifically led to guarantee patient safety and maintain service excellence. RippleDown will certainly assist them in this objective. 


The new agreement commences immediately and is currently for a 12-month period with the option to extend. The value of the agreement is capped at $314,000 per annum. 


PKS’ Managing Director Ron van der Pluijm said, “PKS is looking forward to building a close working relationship with SA Pathology and to assist in delivering better patient outcomes and efficiencies utilising our RippleDown solution".


For further information please contact:

Jane Morgan Management

Investor and Media Relations 

lexi@janemorganmanagement.com.au

+ 61 404 577 076


Media

934619